Christine Meisinger-Henschel

Title: Christine Meisinger-Henschel: Innovator in Immunology

Introduction

Christine Meisinger-Henschel is a prominent inventor based in Neuried, Germany. She has made significant contributions to the field of immunology, holding a total of 16 patents. Her work focuses on the modulation of immune responses, particularly through the use of poxviral proteins.

Latest Patents

Among her latest patents is the invention titled "Modulation of immune responses by the poxviral K4 protein." This invention relates to compositions, methods, and uses involving the modulation of K4 protein activity, especially in the treatment of various diseases and in enhancing vaccination regimens. The invention also encompasses poxviruses with altered K4 protein activity, along with methods for their production and application. Another notable patent is "Vaccinia virus mutants containing the major genomic deletions of MVA." This invention provides modified vaccinia virus genomes and vectors, offering methods for assessing the impact of mutations in VACV on replication competence in specific cell types.

Career Highlights

Christine is currently associated with Bavarian Nordic A/S, where she continues to advance her research in viral immunology. Her innovative work has positioned her as a key figure in the development of new therapeutic strategies.

Collaborations

Throughout her career, Christine has collaborated with esteemed colleagues, including Paul Michael Howley and Paul Chaplin. These partnerships have further enriched her research and contributed to her success in the field.

Conclusion

Christine Meisinger-Henschel's contributions to immunology through her patents and research are invaluable. Her work not only enhances our understanding of immune modulation but also paves the way for innovative treatments in medicine.